Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK J ALBERTS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1992795140
CMS profile
180918
Location
DALLAS, TX

General Payments · PY2018–2024

$308,098.19

  • Reported across 475 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,290.20

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $3,102.70 23
E.R. Squibb & Sons, L.L.C. $104.69 1
PFIZER INC. $31.57 2
Lilly USA, LLC $31.17 2
GE HEALTHCARE $20.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $102,339.69 161
PY2019 $123,208.45 180
PY2020 $32,389.14 37
PY2021 $15,195.74 15
PY2022 $18,510.55 24
PY2023 $13,164.42 29
PY2024 $3,290.20 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $18.15 01/18/2024 Food and Beverage Undisputed 01/23/2026 1104381837 CMS
AstraZeneca Pharmaceuticals LP $73.33 01/18/2024 Food and Beverage Undisputed 01/23/2026 1104578940 CMS
AstraZeneca Pharmaceuticals LP $37.43 02/24/2024 Food and Beverage Undisputed 01/23/2026 1104639507 CMS
AstraZeneca Pharmaceuticals LP $23.66 04/20/2024 Food and Beverage Undisputed 01/23/2026 1105239555 CMS
AstraZeneca Pharmaceuticals LP $20.29 05/08/2024 Food and Beverage Undisputed 01/23/2026 1105630987 CMS
AstraZeneca Pharmaceuticals LP $66.28 05/17/2024 Food and Beverage Undisputed 01/23/2026 1104273837 CMS
AstraZeneca Pharmaceuticals LP $79.54 05/17/2024 Food and Beverage Undisputed 01/23/2026 1104350582 CMS
AstraZeneca Pharmaceuticals LP $14.46 05/17/2024 Food and Beverage Undisputed 01/23/2026 1104385613 CMS
AstraZeneca Pharmaceuticals LP $194.07 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1104441502 CMS
AstraZeneca Pharmaceuticals LP $768.72 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1104628252 CMS
AstraZeneca Pharmaceuticals LP $54.33 05/17/2024 Food and Beverage Undisputed 01/23/2026 1104683585 CMS
AstraZeneca Pharmaceuticals LP $35.79 05/17/2024 Food and Beverage Undisputed 01/23/2026 1104736083 CMS
AstraZeneca Pharmaceuticals LP $768.72 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1105627333 CMS
AstraZeneca Pharmaceuticals LP $133.28 05/17/2024 Food and Beverage Undisputed 01/23/2026 1105873205 CMS
AstraZeneca Pharmaceuticals LP $56.00 05/18/2024 Travel and Lodging Undisputed 01/23/2026 1105226484 CMS
AstraZeneca Pharmaceuticals LP $300.00 05/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105558148 CMS
AstraZeneca Pharmaceuticals LP $14.84 05/31/2024 Food and Beverage Undisputed 01/23/2026 1104258339 CMS
AstraZeneca Pharmaceuticals LP $116.68 06/05/2024 Food and Beverage Undisputed 01/23/2026 1105883507 CMS
AstraZeneca Pharmaceuticals LP $247.58 08/08/2024 Food and Beverage Undisputed 01/23/2026 1105522123 CMS
AstraZeneca Pharmaceuticals LP $14.38 08/22/2024 Food and Beverage Undisputed 01/23/2026 1105479987 CMS
AstraZeneca Pharmaceuticals LP $20.88 08/29/2024 Food and Beverage Undisputed 01/23/2026 1104344106 CMS
AstraZeneca Pharmaceuticals LP $20.87 09/24/2024 Food and Beverage Undisputed 01/23/2026 1105712814 CMS
AstraZeneca Pharmaceuticals LP $23.42 11/08/2024 Food and Beverage Undisputed 01/23/2026 1105640628 CMS
E.R. Squibb & Sons, L.L.C. $104.69 05/13/2024 Food and Beverage Undisputed 01/23/2026 1101257475 CMS
GE HEALTHCARE $20.07 01/10/2024 Food and Beverage Undisputed 01/23/2026 1144682106 CMS
Lilly USA, LLC $14.69 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135118263 CMS
Lilly USA, LLC $16.48 08/22/2024 Food and Beverage Undisputed 01/23/2026 1135168224 CMS
PFIZER INC. $17.09 03/19/2024 Food and Beverage Undisputed 01/23/2026 1131086417 CMS
PFIZER INC. $14.48 04/23/2024 Food and Beverage Undisputed 01/23/2026 1131260568 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.